{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T01:11:21Z","timestamp":1770340281576,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03643-x","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T06:16:25Z","timestamp":1751004985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The clinical outcomes of ultra-low-dose radiotherapy for primary conjunctival mucosa-associated lymphoid tissue lymphoma"],"prefix":"10.1007","volume":"45","author":[{"given":"Xinxin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengting","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Mou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruili","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"issue":"3","key":"3643_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.25122\/jml-2018-0035","volume":"11","author":"P Violeta Filip","year":"2018","unstructured":"Violeta Filip P, Cuciureanu D, Sorina Diaconu L, Maria Vladareanu A, Silvia Pop C (2018) MALT lymphoma: epidemiology, clinical diagnosis and treatment. J Med Life 11(3):187\u2013193. https:\/\/doi.org\/10.25122\/jml-2018-0035","journal-title":"J Med Life"},{"issue":"4","key":"3643_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12185-019-02719-6","volume":"110","author":"Y Kobayashi","year":"2019","unstructured":"Kobayashi Y (2019) JSH practical guidelines for hematological malignancies, 2018. II. Lymphoma-2. Marginal zone lymphoma (MALT lymphoma\/extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue and splenic marginal zone lymphoma). Int J Hematol 110(4):393\u2013405. https:\/\/doi.org\/10.1007\/s12185-019-02719-6","journal-title":"Int J Hematol"},{"issue":"7","key":"3643_CR3","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1136\/bjophthalmol-2019-315637","volume":"105","author":"F Holm","year":"2021","unstructured":"Holm F, Mikkelsen LH, Kamper P, Rasmussen PK, Larsen TS, Sj\u00f6 LD, Heegaard S (2021) Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017. Br J Ophthalmol 105(7):914\u2013920. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-315637","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"3643_CR4","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1001\/jamaophthalmol.2015.6122","volume":"134","author":"MM Kirkegaard","year":"2016","unstructured":"Kirkegaard MM, Rasmussen PK, Coupland SE, Esmaeli B, Finger PT, Graue GF, Grossniklaus HE, Honavar SG, Khong JJ, McKelvie PA, Mulay K, Prause JU, Ralfkiaer E, Sj\u00f6 LD, Toft PB, Vemuganti GK, Thuro BA, Curtin J, Heegaard S (2016) Conjunctival lymphoma\u2013an international multicenter retrospective study. JAMA Ophthalmol 134(4):406\u2013414. https:\/\/doi.org\/10.1001\/jamaophthalmol.2015.6122","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"3643_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13014-020-1477-8","volume":"15","author":"M Niwa","year":"2020","unstructured":"Niwa M, Ishikura S, Tatekawa K, Takama N, Miyakawa A, Kubota T, Kato E, Shibamoto Y (2020) Radiotherapy alone for stage IE ocular adnexal mucosa-associated lymphoid tissue lymphomas: long-term results. Radiat Oncol 15(1):25. https:\/\/doi.org\/10.1186\/s13014-020-1477-8","journal-title":"Radiat Oncol"},{"issue":"4","key":"3643_CR6","doi-asserted-by":"publisher","first-page":"e659","DOI":"10.1016\/j.ijrobp.2011.03.050","volume":"81","author":"JS Goda","year":"2011","unstructured":"Goda JS, Le LW, Lapperriere NJ, Millar BA, Payne D, Gospodarowicz MK, Wells W, Hodgson DC, Sun A, Simpson R, Tsang RW (2011) Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity. Int J Radiat Oncol Biol Phys 81(4):e659\u2013e666. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.03.050","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"3643_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000453615","volume":"3","author":"S Platt","year":"2017","unstructured":"Platt S, Al Zahrani Y, Singh N, Hill B, Cherian S, Singh AD (2017) Extranodal marginal zone lymphoma of ocular adnexa: outcomes following radiation therapy. Ocul Oncol Pathol 3(3):181\u2013187. https:\/\/doi.org\/10.1159\/000453615","journal-title":"Ocul Oncol Pathol"},{"key":"3643_CR8","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.2147\/opth.S463653","volume":"18","author":"Y Matsuo","year":"2024","unstructured":"Matsuo Y, Monden Y, Sasaki K, Akune H, Ikeda S, Ishio D, Murotani K, Nagafuji K, Yoshida S (2024) Treatment outcomes in patients with conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma. Clin Ophthalmol 18:1999\u20132007. https:\/\/doi.org\/10.2147\/opth.S463653","journal-title":"Clin Ophthalmol"},{"key":"3643_CR9","doi-asserted-by":"publisher","first-page":"769530","DOI":"10.3389\/fonc.2022.769530","volume":"12","author":"GJ Min","year":"2022","unstructured":"Min GJ, Kim SE, Kim TY, Jeon YW (2022) Long-term clinical outcomes in treatment-na\u00efve patients with orbital adnexal mucosa-associated lymphoid tissue lymphoma: a single-center study. Front Oncol 12:769530. https:\/\/doi.org\/10.3389\/fonc.2022.769530","journal-title":"Front Oncol"},{"issue":"6","key":"3643_CR10","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/hed.24717","volume":"39","author":"CC Pinnix","year":"2017","unstructured":"Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, Lee HJ, Oki Y, Wang M, Samaniego F, Chi L, Esmaeli B (2017) Ultra\u2013low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma. Head Neck 39(6):1095\u20131100. https:\/\/doi.org\/10.1002\/hed.24717","journal-title":"Head Neck"},{"issue":"5","key":"3643_CR11","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1177\/11206721211035622","volume":"32","author":"MJ Lee","year":"2021","unstructured":"Lee MJ, Lee MY, Choe J-Y, Choi SH, Kim HJ (2021) Ultra-low-dose radiation treatment for early-stage ocular adnexal MALT lymphoma. Eur J Ophthalmol 32(5):3092\u20133096. https:\/\/doi.org\/10.1177\/11206721211035622","journal-title":"Eur J Ophthalmol"},{"key":"3643_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-022-02180-6","author":"X Yang","year":"2022","unstructured":"Yang X, Wang R, Yuan X, Yao S, Wang C, Cheng J (2022) Ultra-low-dose radiotherapy in the treatment of ocular adnexal lymphoma: a prospective study. Radiation Oncol. https:\/\/doi.org\/10.1186\/s13014-022-02180-6","journal-title":"Radiation Oncol"},{"key":"3643_CR13","doi-asserted-by":"crossref","unstructured":"Manta AI, Schlect DJ, Wang DD, Sullivan TJ (2024) Two-year outcomes of ultra-low-dose radiotherapy in the treatment of ocular adnexal B-cell lymphomas. Ophthal Plast Reconstr Surg. https:\/\/doi.org\/10.1097\/iop.0000000000002747.DOI:10.1097\/iop.0000000000002747","DOI":"10.1097\/IOP.0000000000002747"},{"issue":"27","key":"3643_CR14","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/jco.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059\u20133068. https:\/\/doi.org\/10.1200\/jco.2013.54.8800","journal-title":"J Clin Oncol"},{"issue":"3","key":"3643_CR15","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1002\/cam4.5237","volume":"12","author":"K Mizuhara","year":"2023","unstructured":"Mizuhara K, Kobayashi T, Nakao M, Takahashi R, Kaneko H, Shimura K, Hirakawa K, Uoshima N, Wada K, Kawata E, Isa R, Fujino T, Tsukamoto T, Mizutani S, Shimura Y, Yoneda A, Watanabe A, Sotozono C, Kuroda J (2023) Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa-associated lymphoid tissue lymphoma: a retrospective study. Cancer Med 12(3):3134\u20133144. https:\/\/doi.org\/10.1002\/cam4.5237","journal-title":"Cancer Med"},{"issue":"3","key":"3643_CR16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2478\/raon-2024-0048","volume":"58","author":"L Boltezar","year":"2024","unstructured":"Boltezar L, Strbac D, Pizem J, Hawlina G (2024) Ocular adnexal lymphoma\u2014a retrospective study and review of the literature. Radiol Oncol 58(3):416\u2013424. https:\/\/doi.org\/10.2478\/raon-2024-0048","journal-title":"Radiol Oncol"},{"issue":"4","key":"3643_CR17","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/bjophthalmol-2017-310741","volume":"102","author":"SW Nam","year":"2018","unstructured":"Nam SW, Woo KI, Kim YD (2018) Characteristics of primary extranodal marginal zone B-cell lymphoma in Korea: conjunctiva versus other ocular adnexa. Br J Ophthalmol 102(4):502\u2013508. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310741","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"3643_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/ajh.26591","volume":"98","author":"EE Saul","year":"2023","unstructured":"Saul EE, Alderuccio JP, Reis IM, Zhao W, Iyer SG, Rodriguez G, Desai A, Chapman JR, Tse DT, Markoe AM, Isrow DM, Lossos IS (2023) Long-term outcomes of patients with conjunctival extranodal marginal zone lymphoma. Am J Hematol 98(1):148\u2013158. https:\/\/doi.org\/10.1002\/ajh.26591","journal-title":"Am J Hematol"},{"issue":"1","key":"3643_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13014-018-1045-7","volume":"13","author":"K Fukutsu","year":"2018","unstructured":"Fukutsu K, Kase S, Ishijima K, Kinoshita R, Ishida S (2018) The clinical features of radiation cataract in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma. Radiat Oncol 13(1):95. https:\/\/doi.org\/10.1186\/s13014-018-1045-7","journal-title":"Radiat Oncol"},{"issue":"3","key":"3643_CR20","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.ijrobp.2013.11.235","volume":"88","author":"K Harada","year":"2014","unstructured":"Harada K, Murakami N, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, Inaba K, Morota M, Ito Y, Sumi M, Suzuki S, Tobinai K, Uno T, Itami J (2014) Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes. Int J Radiat Oncol Biol Phys 88(3):650\u2013654. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.11.235","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3643_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.eclinm.2018.10.001","volume":"4","author":"YW Jeon","year":"2018","unstructured":"Jeon YW, Yang HJ, Choi BO, Jung SE, Park KS (2018) Comparison of selection and long-term clinical outcomes between chemotherapy and radiotherapy as primary therapeutic modality for ocular adnexal MALT Lymphoma. EClinicalMedicine 4:32\u201342. https:\/\/doi.org\/10.1016\/j.eclinm.2018.10.001","journal-title":"EClinicalMedicine"},{"issue":"1","key":"3643_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/ejh.13765","volume":"109","author":"C Eze","year":"2022","unstructured":"Eze C, Friedrich I, Hadi I, Schmidt-Hegemann NS, Hartoyo SN, Trauth R, Reitz D, Manapov F, Siefert A, Dreyling M, Belka C, Li M (2022) Primary radiation therapy in stage I\/II indolent orbital lymphoma - a comprehensive retrospective recurrence and toxicity analysis. Eur J Haematol 109(1):21\u201330. https:\/\/doi.org\/10.1111\/ejh.13765","journal-title":"Eur J Haematol"},{"key":"3643_CR23","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.2147\/opth.S263291","volume":"14","author":"R Nuzzi","year":"2020","unstructured":"Nuzzi R, Trossarello M, Bartoncini S, Marolo P, Franco P, Mantovani C, Ricardi U (2020) Ocular complications after radiation therapy: an observational study. Clin Ophthalmol 14:3153\u20133166. https:\/\/doi.org\/10.2147\/opth.S263291","journal-title":"Clin Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03643-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03643-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03643-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:06:10Z","timestamp":1766167570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03643-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3643"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03643-x","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This study was approved by Medical Ethics Committee of Shanghai Changzheng Hospital and adhered to the 1964 Declaration of Helsinki. Given the retrospective characteristic of our study, informed consent was waived by Medical Ethics Committee of Shanghai Changzheng Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"269"}}